IOSG Founding Partner: Project Teams' Median Cost for Listing on Top-Tier Exchanges Around $8 Million
BlockBeats News, June 19th, IOSG Founding Partner Jocy stated in a post that a Token is actually a form of debt, and projects should "only issue when absolutely necessary and delay issuance as much as possible."
According to internal observations at IOSG, during the 2024 to 2026 cycle, the median comprehensive listing cost borne by projects on leading exchanges is approximately $8 million, including structural costs such as a security deposit. This number may not apply to all projects, but it reveals an issue that was overshadowed by the previous bull market: issuing a token does not equate to exiting; many times, it merely accelerates the future liquidity pressure.
The valuation at which a project raises funds today determines what milestones need to be achieved in the next three years to support that valuation in the next market cycle. If these milestones cannot be met, the project should not seek funding.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
